J.P. Morgan South Africa Healthcare Seminar

Events

Feb 14, 2022

March 15, 2022
1:00 am to 7:00 am PDT (10:00 to 16:00 SAST)
Dr. Soon-Shiong will be providing an overview of NantWorks, including ImmunityBio, and discuss the healthcare challenges affecting African countries.
Note: J.P. Morgan’s South Africa Healthcare Seminar is for J.P. Morgan clients and not open to the public.
Registration link

Contact us at

+1-844-MY NK CELLS (+1-844-696-5235)

Visit Newsroom

Solutions for Patients

ImmunityBio creates targeted, personalized immunotherapies that are designed to strengthen the immune system and enable it to outsmart your disease.

Opportunities for Trial Investigators

Next-generation adenovirus-vectored anti-cancer vaccines make appealing therapeutics for testing by trial investigators who want to make a contribution to clinical cancer research.

Tools for Research Scientists

Our NK-92® easy-to-maintain and highly cytotoxic natural killer cell line provides a versatile bioanalytical testing tool that can help researchers develop functional killing assays that are more consistent and reliable than donor blood and reporter gene assays.